Синтез оксида азота и развитие атеросклероза

Медицинский центр Управления делами Президента Российской Федерации, Москва

[1] [2] [3] [4] [5] [6] [7]

В начало...

90. Zhang R., Min W., Sessa W.C. Functional analysis of the human endothelial nitric oxide synthase promoter: Spl and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem 1995; 270: 15320-15326.

91. Liao J.K., Clark S.L. Regulation of G-protein alpha i2 subunit expression by oxidized low-density lipoprotein. J Clin Invest 1995; 95: 1457-1463.

92. Luscher T.F., Tanner F.C., Noll G. Lipids and endothelial function: effects of lipid lowering and therapeutic intervention. Curr Opin Lipidol 1996; 7: 234-240.

93. Rubanyi G.M., Vanhoutte P.M. Superoxide anions and hyperoxia onactivated endothelium-derived relaxing factor. Am J Physiol 1986; 250: H822-H827.

94. Ohgushi M., Kugiyama K. Protein kinase С inhibitors prevent impairment of endothelium-dependent relaxation by oxidatively modified LDL. Arterioscler Thromb 1993; 13: 1525-1532.

95. Boulanger С.M., Tanner F.G., Bea M.L. et al. Oxidized low density lipoproteins induce mRNA expression and release of endotelin from human and porcine endothelium. Circulat Res 1992; 70: 1191-1197.

96. Michelson A.D., Benoit S.E., Furman M.I. et al. Effects of endothelium-derived relaxing factor/nitric oxide on platelet surface glycoproteins. Am J Physiol 1999; 270: H1640-H1648.

97. Fujimoto T. Cell biology of caveolae and its implication for clinical medicine. Nagoya J Medical Sciences 2000; 63: 9-18.

98. Pieper G.M. Review of alterations in endothelial nitric oxide production in diabetes. Hypertension 1998; 31: 1047-1060.

99. Cines D.B., Pollak E.S., Buck C.A. et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998; 91(10): 3527-3561.

100. Poston L, Taylor P.D. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Clin Sci 1995; 88: 245-255.

101. Craven P.A., Studer R.K., DeRubertis F.R. Impaired nitric oxide-dependent cyclic guanosine monophosphate generation in glomeruli from diabetic rats. J Clin Invest 1994; 93: 311-320.

102. Michel Т., Li G.K., Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1993; 90: 6252-6256.

103. Tsukahara H., Gordienko D.V., Goligorsky M.S. Continuous monitoring of nitric oxide release from human umbilical vein endothelial cells. Biochem Biophys Res Commun 1993; 193: 722-729.

104. Harrison D.G., Sayegh H., Ohara Y. et al. Regulation of expression of the endothelial cell nitric oxide synthase. Clin Exp Pharmacol Physiol 1996; 23: 251-255.

105. Awolesi M.A., Sessa W.C., Sumpio B.E. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 1995; 96: 1449-1454.

106. Ziegler T.,Bouzourene K., Harrison V.J.etal. Influence of oscillatory and unidirectional flow environments on the expression of endothelin and nitric oxide synthase in cultured endothelial cells. Arterioscler Thromb Vase Biol 1998; 18: 686-692.

107. Ziegler T., Silacci P., Harrison V.J. et al. Nitric Oxide synthase expression in endothelial cells exposed to mechanical forces. J Am Heart Associat 1998; 32: 351-355.

108. Resnick N., Collins Т., Atkinson W. et al. Platelet-derived growth factor B-chain promoter contains a cis-acting fluid shear-stress-responsive element. Proc Natl Acad Sci USA 1993;90:4591-4595.

109. Khachigian L.M., Resnick N., Gimbrone M.A. et al. Nuclear factor-kappa В interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest 1995; 96: 1169-1175.

110. Gimbrone M.A. Jr, Resnick N., Nagel T. et al. Hemodynamics, endothelial gene expression, and atherogenesis. Ann N Y Acad Sci 1997; 811: 1-10.

111. Dimmeler S., Fleming I., Busse R. et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-605.

112. Chartrain N.A., Geller D.A., Koty P.P. et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 1994; 269: 6765-6772.

113. Gibbons G.H., Dzau V.J. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431-1438.

114. Lamas S., Marsden P.A., Li G.K. et al. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992; 89: 6348-6352.

115. Yoshizumi M., Perrella M.A., Bumett J.C., Lee M.-E. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circulat Res 1993; 73: 205-209.

116. Miyazaki H., Matsuoka H., Cooke J.P.etal. Endogenous nitric oxide synthase inhibitor. Circulation 1999; 99: 1141-1146.

117. Boger R.H., Bode-Boger S.M., Szuba A. et al. ADMA: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation 1998; 98: 1842-1847.

118. Wang X.L., Mahaney M.C., Siew A. et al. Genetic Contribution of the Endothelial Constitutive Nitric Oxide Synthase Gene to plasma Nitric Oxide Levels. Arterioscler Thromb Vasc Biol 1997; 17: 3147-3153.

119. Ichihara S., Yamada Y., Fujimura Т., Yokota M. Association of a Polymorphism of the Endothelial Constitutive Nitric Oxide Synthase Gene With Myocardial Infarction in Japanese Population. Am Coll Cardiol 47th An Scientific Session 1998; Abstr: 902- 1001.

120. Park J.E., Hwang Т.Н., Chu J.A. et al. The Association Between a Polymorphism of the Endothelial Nitric Oxide Synthase Gene and the Risk of Acute Myocardial Infarction in the Young Population. Am Coll Cardiol, 47th An Scientific Session 1998; Abstr: 1211-133.

121. Uwabo J., Soma M., Nakayama T. Association of a variable number of tandem repeats in the endothelial constitutive nitric oxide synthase gene with essentinal hypertension in Japanese. Am J Hypertens 1998; 11: 125-128

122. Nakayama Т., Soma M., Takahashi Y. et al. Association analysis of CA repeat polymorphism of Endothelial Nitric Oxide Synthase Gene with Essential Hypertension. Clin Genet 1997; 51: 26-30.

123. Затейщиков Д.А., Минушкина Л.О., Кудряшова О.Ю. и др. Полиморфизм генов NO-синтетазы и рецептора ангиотензина II 1-го типа и эндотелиальный гемостаз у больных ишемической болезнью сердца. Кардиология 2000; 11: 28-32.

124. Hingorani A.D., Liang C.F., Fatibene J. et al. A common variant of the endothelial nitric oxide synthase (Glu298-Asp) is a major risk factor for coronary artery disease in the UK. Circulation 1999; 100: 1515-1520.

125. Liu К., Bai Н., Saku К. et al. A Missense Mutation of the eNOS Gene in Patients with Coronary Heart Disease and Its Possible Interaction with ACE I/D Gene Polymorphism for Coronary Risk. Am Coll Cardiol. 46th An Scientific Session 1997; Abstr: 941-947.

126. Hingorani A., Fan Liang C., Fatibene J. et al. An acidic aminoacid substitution in the putative arginine binding domain of endothelial nitric oxide synthase is a major risk factor for ischaemic heart disease. XIX Congress of the European society of Cardiology 1997; Abstr: 3279.

127. Miyamoto Y., Saito Y., Kajiyama N. et al. Endothelial Nitric Oxide Synthase Gene is Positiviy Associated with Essential Hypertension. Hypertension 1998; 32: 3-8.

128. Затейщикова А.А., Сидоренко Б.А., Воронько О.Е. и др. Полиморфные маркеры гена NOS-3 и гипертрофия миокарда у больных артериальной гипертонией. Материалы Всероссийской научно-практической конференции <Современные возможности эффективной профилактики, диагностики и лечения артериальной гипертонии>. М 2001; 223.

129. Минушкина Л.О., Затейщиков Д.А., Кудряшова О.Ю. и др. Изучение ассоциации эндотелиальной дисфункции и полиморфных маркеров гена NO-синтетазы у больных ишемической болезнью сердца. Дисфункция эндотелия: экспериментальные и клинические исследования. Труды Республиканской научно-практической конференции. Витебск 2000; 145-148.

130. Nakayama М., Yasue Н., Yoshimura М. et al. Т786-С mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm. Circulation 1999; 99: 2864-2870.

131. Searles C.D., Miwa Y., Harrison D.G. Role of the 3' untranslated region in regulation of endothelial nitric oxide synthase gene expression. Circulation 1997; 96 (Suppl 1): 48: Abstr.

132. Hall A.V., Antoniou Н., Wang Y. et al. Structural organization of the human neuronal nitric oxide synthase gene (NOS1). J Biol Chem 1995; 269: 33082-33090.

133. Xie J., Roddy P., File T.K. et al. Two closely linked but separable promoters for human neuronal nitric oxide synthase gene transcription. Proc Natl Acad Sci USA 1995; 92: 1242-1246.

134. Silvagno F., Xia H., Bredt D.S. Neuronal nitric-oxide synthase-p an alternatively spliced isoform expressed in differentiated skeletal muscle. J Biol Chem 1996; 271: 11204-11208.

135. Bloch K.D., Wolfram J.R., Roberts J.D. et al. Three members of the nitric oxide synthase II gene family co-localize to human chromosome 17. Genomics 1995; 27: 526-530.

136. Morrissey J.J., McCraken R., Kaneto H. et al. Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994; 45: 998-1005.

137. Robinson L.J., Michel T. Mutagenesis of palmitoylation sites in endothelial nitric oxide synthase identifies a novel motif for dual acylation and subcellular targeting. Proc Natl Acad Sci USA 1995; 92: 11776-11780.